| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 22/05/2024 | 23:48 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 22/05/2024 | 23:43 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 22/05/2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 22/05/2024 | 22:16 | GlobeNewswire Inc. | Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 20/05/2024 | 22:32 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 16/05/2024 | 22:45 | GlobeNewswire Inc. | Lifecore Biomedical Completes Incremental Liquidity Initiatives | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 19/04/2024 | 22:30 | GlobeNewswire Inc. | Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 01/04/2024 | 14:00 | GlobeNewswire Inc. | Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 26/03/2024 | 21:30 | GlobeNewswire Inc. | Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 20/03/2024 | 12:30 | GlobeNewswire Inc. | Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 20/03/2024 | 12:00 | GlobeNewswire Inc. | Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023 | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 16/02/2024 | 22:05 | GlobeNewswire Inc. | Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 14/02/2024 | 21:39 | Edgar (US Regulatory) | Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 10/01/2024 | 23:22 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 05/01/2024 | 14:00 | GlobeNewswire Inc. | Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 13/12/2023 | 13:30 | GlobeNewswire Inc. | Lifecore Biomedical Provides Business Update | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 20/11/2023 | 22:05 | GlobeNewswire Inc. | Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 18/10/2023 | 22:05 | GlobeNewswire Inc. | Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 17/10/2023 | 11:00 | PR Newswire (Canada) | SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 10/10/2023 | 22:05 | GlobeNewswire Inc. | Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 31/08/2023 | 13:30 | GlobeNewswire Inc. | Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 22/08/2023 | 22:06 | GlobeNewswire Inc. | Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 14/08/2023 | 22:11 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 07/07/2023 | 22:35 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 30/06/2023 | 20:46 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 28/06/2023 | 22:32 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 12/06/2023 | 12:45 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 09/06/2023 | 22:32 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 06/06/2023 | 22:55 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:LFCR | Lifecore Biomedical Inc |
| 05/06/2023 | 22:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:LFCR | Lifecore Biomedical Inc |